222 related articles for article (PubMed ID: 22839094)
1. Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia.
Thakar MS; Bonfim C; Sandmaier BM; O'Donnell P; Ribeiro L; Gooley T; Deeg HJ; Flowers ME; Pasquini R; Storb R; Woolfrey AE; Kiem HP
Pediatr Hematol Oncol; 2012 Sep; 29(6):568-78. PubMed ID: 22839094
[TBL] [Abstract][Full Text] [Related]
2. HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia.
Zecca M; Strocchio L; Pagliara D; Comoli P; Bertaina A; Giorgiani G; Perotti C; Corbella F; Brescia L; Locatelli F
Biol Blood Marrow Transplant; 2014 Apr; 20(4):571-6. PubMed ID: 24462983
[TBL] [Abstract][Full Text] [Related]
3. Successful Outcome in Patients with Fanconi Anemia Undergoing T Cell-Replete Mismatched Related Donor Hematopoietic Cell Transplantation Using Reduced-Dose Cyclophosphamide Post-Transplantation.
Ayas M; Siddiqui K; Al-Jefri A; Al-Ahmari A; Ghemlas I; Al-Saedi H; Alanazi A; Jafri R; Ayas MF; Al-Seraihi A
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2217-2221. PubMed ID: 31306778
[TBL] [Abstract][Full Text] [Related]
4. The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells.
Ayas M; Al-Seraihi A; El-Solh H; Al-Ahmari A; Khairy A; Aldali A; Markiz S; Siddiqui K; Al-Jefri A
Biol Blood Marrow Transplant; 2012 Apr; 18(4):627-32. PubMed ID: 21871862
[TBL] [Abstract][Full Text] [Related]
5. Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.
Mehta PA; Davies SM; Leemhuis T; Myers K; Kernan NA; Prockop SE; Scaradavou A; O'Reilly RJ; Williams DA; Lehmann L; Guinan E; Margolis D; Baker KS; Lane A; Boulad F
Blood; 2017 Apr; 129(16):2308-2315. PubMed ID: 28179273
[TBL] [Abstract][Full Text] [Related]
6. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts.
Boulad F; Gillio A; Small TN; George D; Prasad V; Torok-Castanza J; Regan AD; Collins N; Auerbach AD; Kernan NA; O'Reilly RJ
Br J Haematol; 2000 Dec; 111(4):1153-7. PubMed ID: 11167755
[TBL] [Abstract][Full Text] [Related]
7. CD-34 selected hematopoetic stem cell transplantation from HLA identical family members for fanconi anemia.
Balci YI; Akdemir Y; Gumruk F; Cetin M; Arpaci F; Uckan D
Pediatr Blood Cancer; 2008 May; 50(5):1065-7. PubMed ID: 18000858
[TBL] [Abstract][Full Text] [Related]
8. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.
Chaudhury S; Auerbach AD; Kernan NA; Small TN; Prockop SE; Scaradavou A; Heller G; Wolden S; O'Reilly RJ; Boulad F
Br J Haematol; 2008 Mar; 140(6):644-55. PubMed ID: 18302713
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplant using fludarabine-based reduced intensity conditioning regimen with in vivo T cell depletion in patients with Fanconi anemia.
Gorfinkel L; Demsky C; Pashankar F; Kupfer G; Shah NC
Pediatr Transplant; 2021 Jun; 25(4):e14009. PubMed ID: 33755277
[TBL] [Abstract][Full Text] [Related]
10. Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation.
Grosskreutz C; Ross V; Scigliano E; Fruchtman S; Isola L
Biol Blood Marrow Transplant; 2003 Jul; 9(7):453-9. PubMed ID: 12869959
[TBL] [Abstract][Full Text] [Related]
11. T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor.
Bashey A; Solomon SR
Bone Marrow Transplant; 2014 Aug; 49(8):999-1008. PubMed ID: 24842530
[TBL] [Abstract][Full Text] [Related]
12. Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Lee KH; Lee JH; Lee JH; Kim DY; Park HS; Choi EJ; Ko SH; Seol M; Lee YS; Kang YA; Jeon M; Baek S; Kang YL; Kim SH; Yun SC; Kim H; Jo JC; Choi Y; Joo YD; Lim SN
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1555-1566. PubMed ID: 28552421
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and outcome of haploidentical SCT in pediatric high-risk hematologic malignancies and Fanconi anemia in Uruguay.
Dufort G; Pisano S; Incoronato A; Castiglioni M; Carracedo M; Pagés C; Simon E; Zuccolo S; Barcelona R; Mezzano R; Tiscornia A; Lemos F; Morosini F; Schelotto M; Giordano H; Carreto E; Bengoechea M; Boggia B; Rodriguez I; Guerrero L; Dabezies A; Castillo L
Bone Marrow Transplant; 2012 May; 47(5):663-8. PubMed ID: 21765479
[TBL] [Abstract][Full Text] [Related]
14. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
Tan PL; Wagner JE; Auerbach AD; Defor TE; Slungaard A; Macmillan ML
Pediatr Blood Cancer; 2006 May; 46(5):630-6. PubMed ID: 16078221
[TBL] [Abstract][Full Text] [Related]
15. HLA-haploidentical T-cell receptor αβT/B-cell-depleted stem cell transplantation for Fanconi anemia.
Iguchi A; Uchiyama T; Fujimori K; Gocho Y; Sakaguchi H; Deguchi T; Tomizawa D; Imadome KI; Onodera M; Matsumoto K
Int J Hematol; 2024 Mar; 119(3):334-337. PubMed ID: 38227075
[TBL] [Abstract][Full Text] [Related]
16. Successful Outcome With Fludarabine-Based Conditioning Regimen for Hematopoietic Stem Cell Transplantation From Related Donor in Fanconi Anemia: A Single Center Experience From Turkey.
Kuşkonmaz B; Ünal Ş; Bayhan T; Aytaç Eyüboğlu S; Tavil B; Çetin M; Gümrük F; Uçkan Çetinkaya D
Pediatr Blood Cancer; 2016 Apr; 63(4):695-700. PubMed ID: 26703084
[TBL] [Abstract][Full Text] [Related]
17. An immunoablative regimen of fludarabine and cyclophosphamide prevents fully MHC-mismatched murine marrow graft rejection independent of GVHD.
Petrus MJ; Williams JF; Eckhaus MA; Gress RE; Fowler DH
Biol Blood Marrow Transplant; 2000; 6(2A):182-9. PubMed ID: 10816026
[TBL] [Abstract][Full Text] [Related]
18. HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties.
Giardino S; Eikema DJ; Piepenbroek B; Algeri M; Ayas M; Faraci M; Tbakhi A; Zecca M; Essa M; Neven B; Bertrand Y; Kharya G; Bykova T; Lawson S; Petrini M; Mohseny A; Rialland F; James B; Colita A; Fahd M; Cesaro S; Schulz A; Kleinschmidt K; Kałwak K; Corbacioglu S; Dufour C; Risitano A; de Latour RP
Am J Hematol; 2024 Jun; 99(6):1066-1076. PubMed ID: 38497679
[TBL] [Abstract][Full Text] [Related]
19. Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Children and Adolescents with Fanconi Anemia.
Bonfim C; Ribeiro L; Nichele S; Loth G; Bitencourt M; Koliski A; Kuwahara C; Fabro AL; Pereira NF; Pilonetto D; Thakar M; Kiem HP; Page K; Fuchs EJ; Eapen M; Pasquini R
Biol Blood Marrow Transplant; 2017 Feb; 23(2):310-317. PubMed ID: 27832981
[TBL] [Abstract][Full Text] [Related]
20. Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan.
Chaudhry QUN; Iftikhar R; Satti TM; Mahmood SK; Ghafoor T; Shamshad GU; Farhan M; Shahbaz N; Khan MA; Khattak TA; Rehman J; Humayun S; Satti HS; Anwer F; Ahmed P
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2375-2382. PubMed ID: 31394274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
